G1 Therapeutics Investor Relations Material
Latest events
Study Update
G1 Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from G1 Therapeutics Inc
Access all reports
G1 Therapeutics Inc is a biopharmaceutical company developing therapies for the treatment of cancer. The company focuses on small-molecule drugs designed to preserve bone marrow and enhance the effectiveness of chemotherapy. Its operations span research, clinical development, and regulatory affairs. The company is headquartered in Research Triangle Park, North Carolina, and its shares are listed on the NASDAQ.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
GTHX
Country
🇺🇸 United States